Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
133.6 USD | -0.51% | -1.89% | -6.34% |
Jun. 24 | BNP Paribas Exane Initiates Clorox at Underperform With $130 Price Target | MT |
Jun. 10 | Deutsche Bank Adjusts Price Target on Clorox to $144 From $150 | MT |
Financials (USD)
Sales 2024 * | 7.17B | Sales 2025 * | 7.37B | Capitalization | 16.67B |
---|---|---|---|---|---|
Net income 2024 * | 227M | Net income 2025 * | 728M | EV / Sales 2024 * | 2.66 x |
Net Debt 2024 * | 2.42B | Net Debt 2025 * | 2.33B | EV / Sales 2025 * | 2.58 x |
P/E ratio 2024 * |
73.8
x | P/E ratio 2025 * |
22.7
x | Employees | 8,100 |
Yield 2024 * |
3.57% | Yield 2025 * |
3.72% | Free-Float | 94.83% |
Latest transcript on The Clorox Company
1 day | -0.51% | ||
1 week | -1.89% | ||
Current month | -2.14% | ||
1 month | +1.51% | ||
3 months | -11.94% | ||
6 months | -6.34% | ||
Current year | -6.34% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 46 | 02-12-31 |
Kevin Jacobsen
DFI | Director of Finance/CFO | 57 | 94-12-31 |
Michael Ott
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Allan Mackay
BRD | Director/Board Member | 68 | 16-08-14 |
Director/Board Member | 71 | 15-06-30 | |
Director/Board Member | 66 | 15-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 133.6 | -0.51% | 899,720 |
24-07-01 | 134.2 | -1.63% | 890,039 |
24-06-28 | 136.5 | -0.10% | 1,667,373 |
24-06-27 | 136.6 | +0.97% | 979,490 |
24-06-26 | 135.3 | +0.68% | 1,187,141 |
Delayed Quote Nyse, July 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.34% | 16.67B | |
-21.44% | 37.86B | |
+11.51% | 25.64B | |
-15.86% | 6.91B | |
+2.65% | 5.8B | |
-8.87% | 2.93B | |
-3.29% | 2.15B | |
-0.31% | 1.99B | |
+19.34% | 895M | |
+5.14% | 655M |
- Stock Market
- Equities
- CLX Stock